← FDA Drug Approvals (Drugs@FDA)

CARBOPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2017-04-26

Drug application

FDA Application #

ANDA208487

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARBOPLATIN

Generic name

Carboplatin

Active ingredients

CARBOPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

NOVAST LABS

First approval

2017-04-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown